BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $538,361 | -37.5% | 14,265 | -24.5% | 0.01% | -35.3% |
| Q2 2023 | $860,993 | +184.8% | 18,898 | +153.5% | 0.02% | +183.3% |
| Q1 2023 | $302,334 | +4.7% | 7,454 | +31.5% | 0.01% | -14.3% |
| Q4 2022 | $288,898 | -68.8% | 5,668 | -67.0% | 0.01% | -68.2% |
| Q3 2022 | $925,000 | -17.3% | 17,174 | -1.4% | 0.02% | -8.3% |
| Q2 2022 | $1,119,000 | -24.4% | 17,418 | -8.8% | 0.02% | -11.1% |
| Q1 2022 | $1,481,000 | -9.5% | 19,095 | +0.2% | 0.03% | -6.9% |
| Q4 2021 | $1,637,000 | +9.7% | 19,063 | +2.7% | 0.03% | +3.6% |
| Q3 2021 | $1,492,000 | -11.5% | 18,554 | -11.4% | 0.03% | -6.7% |
| Q2 2021 | $1,686,000 | -2.2% | 20,940 | +2.5% | 0.03% | -11.8% |
| Q1 2021 | $1,724,000 | +7.7% | 20,433 | +2.4% | 0.03% | 0.0% |
| Q4 2020 | $1,601,000 | -1.5% | 19,950 | -1.3% | 0.03% | -17.1% |
| Q3 2020 | $1,625,000 | -4.1% | 20,210 | +2.7% | 0.04% | -6.8% |
| Q2 2020 | $1,694,000 | +17.1% | 19,675 | +10.4% | 0.04% | 0.0% |
| Q1 2020 | $1,447,000 | -8.2% | 17,824 | -5.5% | 0.04% | +12.8% |
| Q4 2019 | $1,577,000 | -7.4% | 18,865 | -3.1% | 0.04% | -15.2% |
| Q3 2019 | $1,703,000 | +7.5% | 19,468 | +0.6% | 0.05% | +7.0% |
| Q2 2019 | $1,584,000 | -5.9% | 19,347 | -6.5% | 0.04% | -4.4% |
| Q1 2019 | $1,683,000 | +18.8% | 20,703 | -3.8% | 0.04% | +2.3% |
| Q4 2018 | $1,417,000 | -19.2% | 21,528 | -5.3% | 0.04% | -2.2% |
| Q3 2018 | $1,753,000 | +1.2% | 22,734 | -3.1% | 0.04% | -4.3% |
| Q2 2018 | $1,733,000 | +15.8% | 23,468 | +2.0% | 0.05% | +23.7% |
| Q1 2018 | $1,496,000 | +5.4% | 23,001 | +4.8% | 0.04% | +2.7% |
| Q4 2017 | $1,419,000 | -2.1% | 21,948 | -5.0% | 0.04% | -5.1% |
| Q3 2017 | $1,449,000 | -1.6% | 23,092 | -5.1% | 0.04% | -4.9% |
| Q2 2017 | $1,473,000 | +9.6% | 24,328 | -6.1% | 0.04% | +7.9% |
| Q1 2017 | $1,344,000 | +6.3% | 25,914 | -9.2% | 0.04% | +2.7% |
| Q4 2016 | $1,264,000 | -22.9% | 28,525 | -17.2% | 0.04% | -22.9% |
| Q3 2016 | $1,639,000 | -4.6% | 34,441 | -9.4% | 0.05% | -5.9% |
| Q2 2016 | $1,718,000 | +34.4% | 38,007 | +22.1% | 0.05% | +30.8% |
| Q1 2016 | $1,278,000 | +5.8% | 31,119 | -1.8% | 0.04% | +8.3% |
| Q4 2015 | $1,208,000 | -63.9% | 31,687 | -68.9% | 0.04% | -64.7% |
| Q3 2015 | $3,344,000 | -48.5% | 101,803 | +9.6% | 0.10% | -43.6% |
| Q2 2015 | $6,496,000 | +19.1% | 92,905 | +16.7% | 0.18% | +22.3% |
| Q1 2015 | $5,452,000 | -14.6% | 79,589 | -8.6% | 0.15% | -19.1% |
| Q4 2014 | $6,385,000 | -2.8% | 87,119 | -4.8% | 0.18% | -6.2% |
| Q3 2014 | $6,569,000 | +8.0% | 91,541 | +8.8% | 0.20% | +6.6% |
| Q2 2014 | $6,082,000 | +4.6% | 84,118 | +6.5% | 0.18% | +5.2% |
| Q1 2014 | $5,815,000 | -0.4% | 79,017 | -5.8% | 0.17% | -7.0% |
| Q4 2013 | $5,836,000 | +81.0% | 83,914 | +70.9% | 0.19% | +65.5% |
| Q3 2013 | $3,225,000 | +64.3% | 49,087 | +73.2% | 0.11% | +48.7% |
| Q2 2013 | $1,963,000 | – | 28,341 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |